artemisinin has been researched along with Carcinoma, Lewis Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gao, J; Guo, Y; Li, G; Wang, J; Xie, Q; Zhang, B; Zhu, B | 1 |
1 other study(ies) available for artemisinin and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Artemisinins; Carcinoma, Lewis Lung; Female; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Survival Rate; Vascular Endothelial Growth Factor C | 2008 |